Athena Countouriotis, Director at Passage BIO, Inc. (PASG), bought 10,000 shares at $14.98 ($150K) on 2020-03-24, disclosed to the SEC on 2020-03-25.
Open-market purchase of $150k PASG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| TPTX | BUY | 2020-05-26 | $250K | — | Filing → |
| PASG | BUY | 2020-03-03 | $160K | — | Filing → |
| TPTX | BUY | 2019-09-11 | $450K | — | Filing → |